1. Home
  2. Investing
  3. Stocks
  4. USA
  6. F star Therapeutics Inc (FSTX)
  7. Quote


F star Therapeutics Stock Price

-0.3963 (-7.61%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 355,529
Bid Price 4.90
Ask Price 5.00
News -
Day High 5.21


52 Week Range


Day Low 4.80
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
F star Therapeutics Inc FSTX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.3963 -7.61% 4.8137 20:00:00
Open Price Low Price High Price Close Price Prev Close
5.21 4.80 5.21 4.95 5.21
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,820 355,529 $ 4.93 $ 1,751,422 - 4.80 - 15.50
Last Trade Time Type Quantity Stock Price Currency
17:57:12 10 $ 4.90 USD


Draw Mode:

F star Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 99.28M 20.62M 20.55M $ 11.26M $ - -9.69 -0.50
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 69.69k 2.50%

more financials information »

F star Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical FSTX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week5.345.944.805.23357,587-0.5263-9.86%
1 Month7.017.134.805.69261,987-2.20-31.33%
3 Months7.918.364.806.56255,389-3.10-39.14%
6 Months6.859.714.806.78199,903-2.04-29.73%
1 Year9.6015.504.807.63164,797-4.79-49.86%
3 Years3.9015.503.907.64169,6360.913723.43%
5 Years3.9015.503.907.64169,6360.913723.43%

F star Therapeutics Description

F-star Therapeutics Inc is a clinical-stage biopharmaceutical company developing tetravalent bispecific antibodies for a paradigm-shift in cancer therapy. By developing medicines that seek to block tumor immune evasion, the company's goal is to offer patients greater and more durable benefits than immuno-oncology treatments.

Your Recent History
F star The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.